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ABSTRACT

This study was designed to investigate whether the ingestion
of ibuprofen prior to or after a 30-min bout of downhill
(-10%) treadmill running would result in reduced sensation
of soreness.

A secondary purpose was to investigate whether

ibuprofen would augment the diminished muscle performance
following downhill running.

Subject consisted of 21 males

(age= 20.3 ± 1.7 years; weight= 77.4 ± 7.8 kg).

Each

subject was randomly assigned to either a control group, a
prophylactic group which received 600 mg of ibuprofen 1 hour
prior to the 30-min treadmill run and (200 mg every 3 hr
postexercise up to 24 hours), or a therapeutic group which
ingested 600 mg of ibuprofen at 24-hours postexercise and
(200 mg every 3 hr till 48-hr postexercise).

Multivariate

ANOVA with a repeated measure revealed no significant
difference in muscle soreness measures at preexercise, 0-hr,
24-hr, and 48-hr postexercise between the control,
prophylactic, or therapeutic groups.

Also, there were no

differences between groups for vertical jump, fatigue index,
maximal anaerobic power, or work capacity at any of the
post-exercise testing times.

Based on these results, the

effectiveness of ibuprofen in regressing exercise-induced
soreness or diminished muscle performance is doubtful.
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CHAPTER I
INTRODUCTION

Soft tissue injuries, like all other tissue injuries,
have plagued physical performance since early human time.
The concept of muscle soreness after strenuous activity is a
universal problem that confronts athletes and other
occupational personnel alike.

Sports participants are

perhaps the worst victims since the problem has its highest
incidence in sports participation (Garrett, 1990).

Because

of its inhibitory effects on performance, exercise
physiologists, athletic coaches, clinicians, trainers, and
athletes have attempted to find antidotes.
Exercise-generated pain presents itself in two basic
forms namely, temporary soreness and residual soreness.
Temporary soreness occurs in the course of exercise and
terminates as activity stops (Friden, 1984).

In residual

soreness, the pain is not felt until approximately 8 hours
after activity and peaks.at 24 to 48-hours postexercise
(Abraham, 1977).

Because of the time lapse between

termination of activity and its occurrence, residual
soreness has been dubbed "delayed-onset muscle soreness"
(DOMS) (Abraham, 1977).

Postexercise soreness is the

symptomatic manifestation of an injury caused to a muscle
tissue (Friden, 1984).

It is the aftermath of strenuous

activity and characteristic of people who routinely do not
perform such activity (Friden, 1984).

Additionally,
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activities that are intensive and extend over a long
duration are also capable of inflicting severe injury
{Armstrong, 1984; Newham, 1988). About 3 to 4 hours after a
damage-inducing exercise, a chain of inflammatory events
involving autogenic destructive processes are believed to
commence in the myofiber {Almekinders

&

Gilbert, 1986).

Phagocytic blood-borne mononuclear cells begin to invade the
damaged site, and by Days 1 and 2 after exercise, the
inflammatory reaction becomes more pronounced (Armstrong,
1990).

Other important changes may also occur during the

pre-invasion period (Armstrong, 1990) however, there is
still much to be understood (Garrett, 1990).
Promoting the inflammatory process are identifiable
mediators such as kinin, histamine, and prostaglandins
(Weissmann, 1982).

Free oxygen radicals have also been

noted as important mediators in the inflammatory process
(Armstrong, 1990; Brune, 1982).

Even though several

mediators are present, considering the critical role of the
cyclooxegenase pathway in the inflammatory reaction, the
resultant prostaglandins may be a primary intermediate in
the inflammatory process (Onyanaugui, 1978).
Inflammation, per se, might not be directly related to
DOMS however, prostaglandins, a mediator of inflammation,
has been shown to be a contributor to DOMS (Ferreira, 1972;
Weissmann, 1982).

No specific factor has been identified as

the primary cause of DOMS but potential physical and
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chemical factors that have.been investigated are rupture to
muscle and connective tissues (Hough, 1902), tonic spasm
(deVries, 1966), and edema (Bobbert, Hollander, & Huijing,
1986; Brendstrup, 1962; Friden, 1984).

The period of DQ~S

is accompanied with a drastic muscle weakness that leads to
diminished muscle performance (Newham, Jones, & Clarkson,
1987).

Presumably, subjects in pain have little voluntary

will to activate the sore muscle which eventually causes
decrements in muscle performance.
In spite of the concurrence of DOMS and diminished
muscle performance, biochemical markers of muscle damage
such as serum creatine kinase and lactate dehydrogenase do
not seem to have the same time course as DOMS.

This

suggests that DOMS may not be responsible for the reduced
functional ability of the injured muscle.

Studies have

indicated that whereas DOMS peaks at 24 to 48-hr
postexercise, diminished muscle performance persists for
over 7 days postexercise.

Results of studies by Herring

(1990) and Newham et al.

(1987) indicated that at the time

of diminished DOMS, functional deficits in sore muscles
existed.

The failure of traumatized muscle to exert maximal

force has been viewed as the result of disorganized muscle
structure (Newham, McPhail, Mills, & Edwards, 1983).
Diminished muscle performance that follows the injury
process has also been attributed to an overextended resting
length of muscle fibers (Friden, 1984).
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The negative impact that mechanical and inflammatory
injuries inflict on subjects have raised concerns in the
area of human performance.

To counteract the ensuing pain

and diminished muscle performance, traditional and modern
preventive and curative modalities have evolved (VanHelder,
1992).

Identifiable classical clinical approaches are heat

therapy; hydrocollator packs and hot immersion; electrical
or ultrasonic devices; cold compress and gallenium arsenide
laser.

Some studies have also investigated such alleviative

approaches as exercise (Appell, Soares,

&

Duarte, 1992;

iontophoresis (Hasson, Wibble, Reich, Barnes,

&

Williams,

1992), and trolamine salicylate (Ciccone, Leggin,
Callamaro, 1991).

&

Another modality that has frequently been

prescribed in recent times is designated as nonsteroidal
anti-inflammatory drugs (NSAIDs) which include ibuprofen,
aspirin, and naproxen as will as diclofenac, piroxicam,
flurprofen, etodolac, diflunisal, oxaprozin, nabumetone,
azapropazone, fenoprofen, fenbufen, tolmetin, and sulindac
(McCormack

&

Brune, 1991).

The mechanism by which ibuprofen exerts its effect on
DOMS is still unknown however, three mechanistic modes have
been proposed namely: (a) analgesia, the shielding of pain
nerve endings from pain stimuli; (b) anti-nociception,
chemically blocking muscle excitation in injured muscles;
and (c) anti-inflammation which involves the blocking of
cyclooxygenase enzyme which catalyzes the biotransformation
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of arachidonic acid.

Although not universally accepted,

current thought is that NSAIDs inhibit the synthesis of
prostaglandins to achieve the analgesic efficacy (Brune et
al., 1991).

McCormack and Brune (1991) have suggested that

the anti-nociceptive action of NSAIDs could be tied to the
inhibition of accumulation of prostaglandins and other
mediators of inflammation.

They further argue that the two

modes of action, analgesia and nociception differ only in
terminology, but that the chemical processes are basically
the same.
Studies that attempt to establish a link between antiinflammation and analgesia of NSAIDs have suggested that the
two mechanisms are inseparable (Ciccone et al., 1991; Hasson
et al., 1993).

Some NSAIDs are also believed to be

scavengers of the hydroxyl radical (OH-) (Famaey, 1982).
The scavenging action hastens the transformation of PGG2
(inflammatory) to PGH2 (less inflammatory) (Onyanaugui,
1978).

There seems to be a clear association among DOMS,

diminished muscle performance and muscle damage.

The damage

itself can be attributed to mechanical and biochemical
processes.

Using NSAIDs may thus provide reliable

intervention to DOMS through such mechanistic modes as
analgesia, antinociception, and anti-inflammation.
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Statement of the Problem
The purpose of this study was to investigate the
effects of ibuprofen ingested either prophylactically or
therapeutically on delayed-onset muscle soreness and on
muscle performance following an eccentric-biased running
bout.
Significance of the Study
Previous studies have investigated the effectiveness of
ibuprofen in reducing DOMS and diminished muscle performance
but produced conflicting results.

Most studies have focused

on subjective assessment of DOMS to evaluate the efficacy of
drugs disregarding the deleterious effects of the injury on
muscular performance.

Due to the inconclusiveness of such

investigations the present study is warranted.
Research Hypotheses
The research hypotheses are as follows:
1.

Ibuprofen would diminish DOMS.

2.

Ibuprofen would help restore muscle performance

more quickly than without.
3.

Prophylactic treatment with ibuprofen would be more

effective than therapeutic in reducing DOMS and restoring
muscular performance.
Assumptions
The following assumptions were made:
1.

Subjects exerted maximal effort on the cycle

ergometer and in the vertical jump test.
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2.

Subjects abstained from ingesting NSAIDs or

additional dosages of ibuprofen or other NSAIDs before and
after the exercise treatment or employing any intervention
mode to alleviate soreness.
3.

Motivation was equally high in all subjects.

4.

Subjects honestly indicated their true extent of

soreness perception on the analogue scale.
5.

Instruments and tests used in the study were

accurate, reliable, and valid.
6.

Pre-testing did not influence post-test scores.

7.

There was consistency.and reliability in the

soreness measuring scale, the Wingate and vertical jump
tests.
Delimitation of the Study
This study was delimited to the following:
1.

Twenty-one volunteer male students of the

University of Northern Iowa.
2.

Students who were not participating in any

intercollegiate sport at the time of the study.
3.

Students between 18 and 33 years of age.

4.

Healthy individuals (subjects who 3 months prior to

the study, had not been referred to a physician for any
muscle injury treatment).
5.

Running on a Quinton 18-60 or a Marquette 2000 T

motor-driven treadmill in the Human Performance Laboratory
of the University of Northern Iowa.
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6.

The visual analogue scale used to measure soreness.

7.

The vertical jump and Wingate cycle ergometer

tests.
Limitations of the Study
The following were limitations of the study:
1.

The inability to ensure equal efficacy of the drug

in all subjects based on varying individual body composition
and metabolism.
2.

The possibility that subjects may take extra

dosages of ibuprofen or other NSAIDs.
3.

The uncertainty of honesty or otherwise with which

subjects disclosed muscle soreness.
4.

The validity and reliability of the testing

instrument, soreness measurement scale, vertical jump, and
the Wingate tests.
Definition of Terms
1.

Prophylactic--the administration of ibuprofen

before activity.
2.

Therapeutic--the ingestion of ibuprofen 24 hours

after exercise when soreness begins to reach its peak.
3.

Concentric work--movement in which the muscle

shortens as it produces force.
4.

Eccentric work--movement in which the muscle

lengthens as it produces force.
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7.

Antioxidants--substances that help reduce the

degree of oxygen stress either by forming a lesser active
radical or inhibiting the reaction.
8.

Nociceptor--a drug that has the potential to shield

pain receptors.
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CHAPTER

II

REVIEW OF LITERATURE
To date, the use of ibuprofen and other pharmacological
modalities as an antidote to exercise-induced muscular
soreness has not exhaustively addressed the issue of dosage,
timing, efficacy in performance restoration, and, most
importantly, its mode of action.

The present study was

therefore designed to investigate whether the oral ingestion
of ibuprofen before or after treadmill running would reduce
pain sensation and more quickly restore muscular
performance.
Of the soft tissues injuries associated with sports,
overload injuries to muscle fibers seem to be the most
prevalent (Glick, 1980; Ryan, 1969).

Victims to such damage

show such symptomatic signs as pain (Newham, 1988),
swelling, anatomical deformity, and athletic dysfunction
(Kibler, 1990; Newham et al., 1987).

The cost of muscle

damage to athletes is enormous and in instances of
relatively high performance, the cost is expressed in terms
of high energy expenditure leading to further injuries
(Kibler, 1990).
Muscle soreness and occasional diminished muscular
performance that follow tissue damage are attributable
primarily to mechanical damage and secondly, to inflammatory
responses as part of biochemical reactions to the initial
fiber damage (Almekinders

&

Gilbert 1986).
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Muscle Damage
There is very little clarity about the mechanism that
leads to DOMS.

Ebbeling and Clarkson (1989) however,

suggest that mechanical and biochemical factors as discussed
below, could be causative.
Mechanical Disruption of Cells
Mechanical stress on muscle fiber is believed to be
very instrumental in generating structural disruptions which
later subjects the muscle to further damage through
biochemical reactions.

Arguments in favor of mechanical

processes as potential cause of muscle damage has been
investigated and is tied to eccentric motion.

In a study

by Mccully and Faulkner (1985), eccentric motion resulted in
greater injury to muscle fibers than did isometric or
concentric activities.

Muscles of female albino mice were

stimulated through isometric contraction and lengthening
activity.

Tissue preparations following the eccentric

protocol revealed greater damage to the fibers.
Almekinders (1993) further suggested that during long
distance running, each running cycle involves a shortening
and lengthening process of the muscle.

The singular impact

of this process is less than enough to cause injury to the
muscle tendon unit, but the summative effect could be
enormous.
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Faulkner, Brooks, and Opitek (1993) suggested that
injury from eccentric motion is attributable to the
increased tension per individual cross bridge.

Force

development by a fiber during eccentric motion is
approximately two times that developed during isometric
movements, yet there is only a 10% increase in the number of
cross bridges in eccentric motion (Faulkner et al., 1993).
With a higher fiber to force ratio, mechanical disruption
may occur to the ultrastructural elements in the muscle
fibers such as the Z-line and contractile filaments and
associated connective tissues (Armstrong, 1984).

Duration

and intensity of activity have also been shown to play an
important role in fiber damage (Armstrong, 1984; Newham,
1988).

Although Tiidus and Ianazzo (1983) have suggested

that intensity of activity has greater potency in causing
muscle soreness than the duration of exercise, tendency for
a negatively moving muscle fiber to be damaged is still
great.
Muscle types which have greater vulnerability to damage
are: (a) two-joint muscles, (b) Type II fibers, and (c)
muscles involved in eccentric motion (Garrett, 1990).

His

views are suggestive that activities which require burst,
speed, and high tension recruit a greater percentage of Type
II fibers and, due to the higher speed of contraction, the
Type II muscles are likely to be predisposed to injury.
evidence, Friden (1984), had subjects perform eccentric

As
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movement on a modified cycle ergometer.

Micrographs from

prepared tissues showed 4:1 ratio of Z-band anomalies for
Type II to Type I fibers.

Histological and ultrastructural

analyses of muscle fibers indicate that whereas the Z-disk
appears as a square lattice (Hoppeler, 1986), under damaged
conditions the Z-disk shows streaming, broadening, and
disruption in electron micrographs (Friden, 1984).
Myofibrilla and sarcolemmal disruptions and widening of A
band and I bands were also seen as signs of damaged muscle
fibers (Armstrong, Ogilvie,

&

Schwane, 1983).

Biochemical Damage
The principal response involved in biochemical damage
is inflammation at the site of the initial mechanical
damage.

Inflammation is in itself characterized by movement

of fluid and migration of neutrophils and monocytes to the
damaged area.

Biochemical response help to promote

clearance of damaged tissues, eliminate microbial invaders,
and also promote tissue repair (MacIntyre, Darlene,
McKenzie 1995).

&

Little is known as to when the injury

process starts, but the inflammatory response is believed to
follow the injury approximately between 3 and 4 after the
damage (Armstrong, 1990).

The associated pain sensation

appears about 8 hours post-activity (Newham, 1988).
Inflammation is associated with an initial
vasoconstriction that lasts for 5-10 min followed by
vasodilation, increased vascular permeability, and extrusion
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of blood products into the surrounding tissues causing edema
(Abramson

&

Weissmann, 1985).

This is followed by

recruitment of inflammatory cells such as leukocytes and
macrophages which attract neutrophils to the injured site
(Armstrong, 1990).

Neutrophils have the ability to release

agents that assist in the digestion of surrounding dead
tissue cells.

Since neutrophils have difficulty

distinguishing between damaged and healthy tissues, healthy
tissues may be mistaken for damaged or foreign bodies
(Weiss, 1989).

Under such circumstance, toxic agents are

released by the neutrophils to attack healthy tissues,
culminating in oxidative damage and further inflammation
(Weiss, 1989).

Neutrophils are also capable of causing

tissue injury through the release of oxygen radicals.
Oxygen radicals are highly reactive chemical species that
have one or more unpaired electrons in the outer shell.

In

creating lipid peroxidation, free oxygen radicals decrease
the barrier function of cell membranes.

Free oxygen

radicals are believed to be associated with necrosis and
enzyme release following damaging exercise (Ebbeling

&

Clarkson, 1989).
Prostaglandins, Mediator of Inflammation
The origin of prostaglandins and the associated
inflammatory symptoms including pain, redness, and swelling.
Whereas some authors hypothesize prostaglandins as able to
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sensitize pain endings to specific mediators (Brune, MenzelSoglowak,

&

Zeilhfer, 1992), others consider prostaglandins

as modulators of inflammation (Willoughby

&

Sedgwick 1982).

Onyanagui (1978) yet proposed that prostaglandins can
potentiate the increased vascular permeability under the
influence of other mediators namely, histamine, serotonin
and kinin, which will likely cause edema.

Prostaglandins

are classified into stable such as PGE2 and PGF alpha and
unstable example, PGEl (Wiessmann, 1982).

PGEl is a

vasodilator which, when injected into normal human skin,
produces erythmia and pain.

PGEl has also been shown to act

with bradykinin and histamine to potentiate edema.

The

presence of prostaglandins in damaged muscles was observed
in a study by Bansil, Wilson, and Stone (1986).

After

having 32 males perform squats, aspirin and placebo were
administered.

Blood drawn at preexercise and every 12 hours

postexercise up to 72 hours was analyzed by
radioimmunoassay.

The results showed a significantly

increased plasma levels of PGEl and PGF2 alpha in the
placebo group.
Prostaglandins and the Cyclcooxygenase Pathway
The association between prostaglandins and the
cyclooxenase pathway during inflammation is seen in the
biotransformation of arachidonic acid in which
cyclooxygenase plays a catalytic role.

Arachidonic acid is

a natural component of phospholipids in cell membrane and is
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released from phospholipids in the presence of phagocytic
cells (Weissmann, 1982).

In the oxidation of arachidonic

acid, cyclooxygenase and other enzymes act as catalysts to
produce thromboxanes A2 and prostalandins.

Thus, the extent

of inflammation caused by mediating prostaglandins can be
speculated to depend on the amount of cyclooxygenase
available to catalyze the oxygenation of arachidonic acid.
The same reaction produces an unstable endoperoxide, PGG
which after oxidation produces hydroperoxy endoperoxide.

In

the end, free oxygen radicals are liberated to cause further
damage (Allessio, 1993; Grisham & McCord, 1986; Jenkins &
Goldfarb, 1993).
The presence of tissue and cellular artifacts
have variously been used as markers of tissue damage.

After

having subjects perform eccentric work, Clarkson,
Litchfield, Graves, Kirwan, and Byrnes (1985) observed
significantly greater muscular soreness and elevated muscle
enzymes in the blood.

Similar findings were made by

Kuipers, Keizer, Verstappen, and Costill (1985) in a study
in which three subjects performed an eccentric work bout for
45 min and one for 60 min at 80% of the individual's maximal
work load on a cycle ergometer.

In all the 4 subjects used,

moderate increases of muscle enzymes were observed.

In

addition, plasma concentration of creatine phosphokinase
peaked at 24-hours postexercise.
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Consequences of Muscle Fiber Damage
Consequent to mechanical and biochemical damage to the
muscle fiber, delayed-onset muscle soreness results along
with a reduction in muscular force in the affected areas.
Nonetheless, the time course of the two phenomena do not
seem to be related.
DOMS and Theories of Origin
Opinions are divided on the chemical or physical agents
that stimulate DOMS (Armstrong, 1984) which is felt
approximately, 8 hours postexercise and peaking at 24 to 48
hours after exercise (Abraham, 1977; Tiidus
1983).

&

Ianazzo,

DOMS is the aftermath of a strenuous activity and is

characteristic of people who are not accustomed to such
activities (Friden, 1984).

Three causes of DOMS have been

proposed namely, torn tissue (Hough, 1902), tonic spasm
(deVries, 1966), and edema (Brendstrup, 1962).
The Torn Tissue Theory
From electromyographic (EMG) studies conducted by Hough
(1902), muscle soreness observed in untrained individuals
after heavy resistance work added to loss of contraction
strength.

Hough suggested the cause of the pain as due to

rupture within the muscle itself or the connective tissue
that transmits the pull of the fibers to the tendons.
Tenderness is restricted to musculotendinous attachments, so
that in the process of contraction, muscles pull on the
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injured tendons to cause pain (Newham, Mills, Quigley,
Edwards, 1983).

&

The Torn Tissue model however, has not

received substantial support over the years.
Tonic Spasm Theory
deVries (1966) explained DOMS from an EMG point of
view.

The results of his investigations revealed a greater

resting motor unit activity in sore muscles than in control
subjects.

He proposed the possibility that spasms within

motor units can be the cause of DOMS.

He also suggested

that severity of the tonic activity is a factor of the
number of motor units involved.

A report by Cobb, deVries,

Urban, and Leukens (1975) indicated that increases in EMG
activity may be accompanied by muscle pain perception.
Supporting this view, Bobbert et al. (1986) concluded that
if tonic muscular spasm of motor units is present and is
severe enough to partially occlude blood vessels, ischemia
could result causing pain.

Bobbert et al. (1986) had 11

subjects perform plantar-dorsiflexion with one leg on a 20cm thick board while the other leg was held off the floor.
Results of this study showed tonic spasm in some of the
subjects.

Even if all the subjects experienced pain or

otherwise it is difficult to speculate if the discriminatory
spasm is the actual cause of the pain.

In a study conducted

by Kami and Viitalaso (1977) however, pain was inferred as a
probable cause for increased neural activation since more
central activation, at a given tension, is required for sore
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muscle compared to healthy ones.

Komi and Viitalaso (1977)

had four subjects perform concentric and eccentric exercises
by exerting 40 maximal contractions, each lasting for 3.5
sec with a 11.5 sec break.

Knee angle was set at 107

degrees and subject instructed to exert maximal force on an
electromechanical dynamometer.

EMG was recorded

continuously before, during, immediately, and 2 days after
the work.

Muscle tension averaged for each contraction

decreased substantially more in eccentric than in concentric
fatigue conditions.

An integrated EMG analysis showed that

substantially more neural energy was needed for the
production of certain muscle tension after fatigue loading
than before.
Edema and Intramuscular Pressure
In a study conducted by Brendstrup (1962) using
rabbits, an increase in water and chloride concentration
were observed in the exercised muscles 24-48 hours after
exercise but disappeared by 6 days.

Since the time courses

for postexercise pain and increased fluid content were
similar, he attributed the pain to edema.

Talag (1973)

supported the edema model after observing increased limb
volume at 24-, 48-, and 72-hours post-exercise which was
accompanied with subsequent soreness.

Fritz and Stauber

(1988) used histological procedures to observe changes in
the extracellular matrix of rat muscle 24 hours after
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eccentric exercise.

They suggested that disruption of

proteoglycan components result in movement of water to the
extracellular matrix through increased osmotic force.
Diminished Muscle Performance and Causes
There seems to be very little known about the duration
of diminished muscle performance following muscle injury.
Clarkson and Tremblay (1988) observed loss of performance up
to 1-hour postexercise.

Sergeant and Dolan (1987) had four

subjects perform repeated eccentric contraction with leg
extensor in a prolonged downhill (-25% grade) walking.
Muscle function, expressed in terms of maximum voluntary
contraction and short-term power output remained diminished
for 96-hour postexercise.
There is little in the literature on what causes loss
in strength (MacIntyre, Darlene,

&

McKenzie, 1995).

Studies

have however speculated that the loss in muscle performance
is attributed to biochemical and mechanical media namely,
DOMS, edema, disorganized muscle morphology, or a
combination.
DOMS

Several studies have supported the notion that the time
of soreness sensation is occasioned with severely reduced
muscle strength.

The reasoning behind this is that during

the periods of DOMS, victims feel very reluctant to
voluntarily activate a muscle to move a limb.

Newham et al.

(1983) suggested that tenderness was restricted to
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musculotendinous attachments, and as the muscle contracts, a
pulling action is made on the injured tendons to cause pain.
Because of the voluntary nature of movement, the existence
of pain will offer victims little voluntary will to contract
the sore muscles to generate maximal force.
Muscle Morphology
Muscle damage is associated with disorganization of the
contractile material within the muscle fibers
(Friden, 1984).

The immediate loss of function may be due

to overstretched sarcomeres.

As a result, actin and myosin

filaments are separated due to the high tension developed
from the initial eccentric work which impairs force
production.

Faulkner et al. (1993) suggested that some

sarcomeres stretch beyond a physiological limit during
eccentric activity and become injured.

Although there may

be some metabolic involvement, Faulkner et al.

(1993)

believe that the initial decline in force may be a function
of fatigue and mechanical injury which results in
my-0fibrilla disruption at the Z-line level.
Bi:Qchemical Factors (Calcium Extrusion and ATP Loss)
Two substances considered to initiate biochemical
damage are ATP and calcium.

When actin and myosin are

pulled apart, the sarcolemma is damaged allowing entry
of extracellular calcium.

Increased intracellular calcium

in muscle cells from a damaged muscle sarcolemma or
sarcoplasmic reticulum can induce biochemical damage to an
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already mechanically damaged muscle fiber (Armstrong, 1984;
Armstrong, 1990).

A principal enzyme that has been

identified as the underlining factor in the calcium pathway
is phospholipase A2 (Duncan

&

Jackson, 1987).

One action of

phospholipase A2 is the breakdown of fatty acids and
lysophospholipids in the sarcolemma (Armstrong, 1990).
Fatty acids may in turn produce prostaglandins which will
eventually mediate inflammatory reactions.
Fiber Cross-sectional Area Model
Friden (1984) explained the loss of contractile
strength as due to the reduction in cross-sectional area of
the injured muscle fiber.

This is in accordance with the

reasoning that a muscle fiber exert force directly
proportional to its cross sectional area (Garrett, 1990).
In a study by Mccully and Faulkner (1985), the left extensor
digitorum longus of female albino mice were stimulated and
performed isometric, shortening, or lengthening
contractions.

Similar muscles of the contralateral leg were

used as a control.

The results showed decrements in force

at Day 3 in muscle which underwent lengthening contraction
and also a strong correlation between loss in force and
shrinkage in the total cross-sectional area.
Physiological reactions in the body following
biochemical and physical damage give rise to pain and
reduced muscle performance.

Whereas tonic spasm, edema and

torn tissue have been speculated to mediate the pain,
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diminished muscle performance is essentially believed to
arise from pain, loss of calcium from the sarcolemma,
overextended fiber length and emaciated fiber cross
sectional area.
Soreness Alleviating Procedures
Athletes who sustain muscle injuries show several
clinical signs including pain, swelling and such functional
deficiencies as anatomical deformity, and athletic
dysfunction (Kibler, 1990).

He suggested that treatment of

muscle injury must be geared towards reestablishing function
rather than relief of symptoms.

Traditional procedures of

alleviating DOMS have constituted thermal therapy,
cryotherapy, and physical therapy.

In recent times,

supplementary sources have been found in the form of
pharmacological resources, predominantly non-steroidal antiinflammatory drugs (NSAIDs).

NSAIDs are medicinal agents

which are believed to inhibit the process of biochemical
cellular degradation in soft tissues involved in
inflammation.

The mode of action of NSAIDs is thought to be

inhibiting the synthesis and release of prostaglandins and
inhibition of neutrophils (Abramson, Edelson, Kaplan,
Ludewig,

&

Weissmann, 1984).

Common examples of NSAIDs

easily available for use currently are aspirin and
ibuprofen.
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Mechanism Of Action Of NSAIDs
NSAIDs have been noted for their ability to act as an
inhibitor to prostaglandins synthetase (Boots Lab leaflet,
1994; Brune, 1982).

In spite of the confusion regarding

their pharmacology, researchers believe that NSAIDs act in
the following three related ways.
Analgesia
The analgesic action of NSAIDs is observable from its
ability to inhibit prostaglandin synthesis (McCormack
Brune, 1991; Brune et al., 1991).

&

A study conducted by

Brune et al. (1992) looked at changes in pain perception
that result from tissue dam.age.

The researchers suggested

that tissue dam.age induced by prostaglandins can transform
fine nerve endings of high threshold mechanoreceptor into a
nociceptor.

This transformation combines with increased

reflex activity in the dorsal horn of the spinal cord to
generate hyperalgesia associated with tissue dam.age.

By

inhibiting prostaglandin activities, NSAIDs reduce the
nociceptive process.
Anti-Nociception
Braga, Biella, and Tiengo (1987) investigated the antinociceptive action of aspirin and tenoxicam. on adjuvantinduced arthritis in rats.

They reported that intravenously

administered aspirin (54 mg/kg) produced a marked antinociceptive effect within 8 minutes.

McCormick and

Brune (1991) reported that NSAIDs possess antinociceptic
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features which make them capable of shielding the injured
site from pain sensation.

This shielding mechanism could be

critical in protecting pain nerve endings of the injured
muscles.

Presumably it serves as chemical blocks to

excitations that could otherwise generate pain sensation in
the affected sites.
Anti-Inflammation
The anti-inflammatory effect of aspirin and
indomethacin may be attributed to its ability to inhibit the
cyclooxygenase enzyme, a catalyst to the metabolism of
arachidonic acid.

By inhibiting the catalytic activities of

cyclooxygenase, the biotransformation of arachidonic acid to
thromboxanes and endoperoxides is prevented (Weissmann,
1982).

As a result, the production of endoperoxides and

inflammation mediators are blocked (Onyanaugui, 1978).
Since the quantity of thromboxanes, a mediator of
inflammation is reduced, less inflammatory reaction is
likely to occur.

NSAIDs are also believed to inhibit oxygen

radicals and are capable of scavenging OH-, thus
transforming PGE2 (inflammatory) to PGH2 (less inflammatory)
(Onyanaugui, 1978).
In regressing inflammation, Almekinders (1993)
recommended treatment to be aimed at initial symptoms of
inflammation whereas subsequent treatment should be geared
towards repair of the damaged muscle fibers.

He further

suggested the use of NSAIDs after injury but for a
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relatively shorter period of time so as not to interfere
with the subsequent muscle repair and remodeling process.
This assertion was substantiated in a study by
Almekinders and Gilbert, (1986) using three groups of
Sprague-Dawley rats.

Group 1 underwent muscle strain of the

tibialis anterior muscle.
injury period.

They then rested in the post-

In Group 2 similar muscle was strained but

piroxicam (10 mg/kg) was administered.

Group 3 had no

strain, immobilization, nor drug treatment.

Histological

evaluation showed hemorrhage and muscle fiber disruption
along the strain.

At Day 2, the group that underwent muscle

strain showed extensive invasion of macrophages.

There was

but slight inflammation in the piroxicam treatment group
with little monocytic response.

Muscle tissues in the third

group had normal microscopic appearance and also showed
evidence of muscle regeneration.

The delay in muscle

regeneration of muscle fibers in the treatment group was
attributed to the inhibition by piroxicam to inflammation.
Ibuprofen has been studied on a limited scale in terms
of its effect on DOMS.

The few investigations conducted

using ibuprofen and/or related NSAIDs have had conflicting
conclusions regarding its efficacy in reducing DOMS and
restoring muscle performance.
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In a study by Donnell.y, Maughan, and Whiting (1990),
ibuprofen did not reduce muscle soreness nor restore muscle
strength after 32 subjects performed two bouts of downhill
treadmill running separated by ten weeks.

Group 1 (N = 16)

received ibuprofen at first period and placebo at the
second.

Group 2 (N = 16) received placebo at first, but

ibuprofen at the second period.

Subjects ingested 600-mg

ibuprofen or placebo 30 minutes before each exercise bout
and took another 600 mg every 6 hours up to 72 hours postexercise for a total of 8,400 mg.

Preexercise, 16-hr, 24-

hr, 48-hr, and 72-hr postexercise measures of muscle
soreness indicated significant increases in total muscle
soreness after each exercise bout.

However, no difference

in soreness response existed between the two treatments nor
the first or second downhill run.

Measurements of maximal

voluntary force or isometric contraction of the legs
decreased about 10% from initial leg strength.

The group

that received ibuprofen for the first bout and placebo for
the second bout demonstrated the greatest decline in
strength following exercise irrespective of treatment.
Based on the results of this study, the researchers
concluded that at a dosage of 600 mg/6 hour, ibuprofen is
not effective in reducing DOMS nor muscle strength loss.
They further suggested that DOMS may not be the result of
inflammation.
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In a similar study by Hasson et al. (1993),
prophylactic or therapeutic use of ibuprofen were both found
to be effective in reducing DOMS and improving muscle
performance compared to placebo and control conditions.

The

20 subjects involved in this study were randomly assigned to
a prophylactic group who ingested 400 mg of ibuprofen 4
hours prior to the exercise or additional 800 mg over the
next 24 hours; a therapeutic group which took 400 mg of
ibuprofen at 24 hours postexercise and 800 mg over the
following 24 hr; placebo group; and a control group.

The

exercise protocol involved step-ups on a bench that was 110%
in height of the lower leg length while carrying an
additional load that was 10% of subjects body weight.

Pre-

exercise, 24-hr, and 48-hr postexercise muscular
performance, creatine kinase and soreness perception were
evaluated.

The prophylactic ibuprofen group reported

significantly less soreness than the therapeutic, placebo or
control group.

At 48-hr.postexercise, soreness was

significantly less for prophylactic ibuprofen group than for
the placebo and control groups.

Maximal isometric

contraction by an EMG as a percentage of change from
baseline measures indicated that in all groups, maximum
voluntary contraction was significantly reduced at 24 hours
relative to baseline measures.

The prophylactic group

significantly decreased less in isometric force production
than the therapeutic, placebo or control group.

At 48

29

hours, maximum voluntary contraction declination from
baseline value was significantly less than that of the
placebo and control groups.

They suggested that if the

development of muscle soreness is an indication of
inflammatory response, and a relationship exists between the
magnitude of DOMS and inflammation, then the reduced
soreness exhibited by the treatment groups will show
markedly attenuate inflammation.
Summary
There is evidence in the literature which supports the
view that DOMS arises from an initial mechanical damage.
Following the trauma, biochemical reactions autogenic to the
muscle fiber ensue.

Evidently, eccentric motion is a

plausible cause for the initial muscle injury.

Later, the

injury manifests itself in the form of inflammatory reaction
and DOMS.

An interplay of DOMS, disorganized muscle

morphology, calcium loss, and ATP shortage then generate
diminished muscle performance.

Traditional and modern

procedures ranging from cryotherapy, thermal therapy,
physical therapy and pharmacological modalities have been
prescribed to alleviate DOMS.

Clinicians and physical

therapists have resorted to and frequently prescribed the
use of such pharmacological sources as aspirin, piroxicam,
indomethacin and ibuprofen, generally referred to as NSAIDs.
In spite of the popularity among users, ibuprofen does not
seem to reduce DOMS or diminished muscle performance.
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CHAPTER III
METHODS
The primary purpose of this study was to determine
whether the oral ingestion of ibuprofen would cause a
reduction in the sensation of muscle soreness that results
from physical activity.

The secondary purpose was to

determine if ibuprofen can restore muscle performance more
quickly than nontreatment group.

A third purpose was to

determine whether pre-exercise or post-exercise treatment of
ibuprofen would generate differential effects on muscle
soreness and degraded muscle performance.
Subjects
Twenty-nine male non-athletes from the University of
Northern Iowa between the ages of 18 and 33 years
volunteered to participate in this study.

Eight subjects

were unable to complete all phases of the study for various
reasons, leaving 21 subjects that participated in the.
research.

The subjects were not engaged in any regular

sports training requiring leg power nor had sustained any
lower limb injury in 3 months prior to participation.
All were fully informed of the nature and risk involved
in the procedures to be used, and they provided informed
consent.

Subjects were instructed to abstain from exercise,

ingesting alcohol, smoking, massage, using anti-inflammatory
drugs, analgesics or thermal modalities during their
involvement in the

study.
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Experimental Procedure
All testing was conducted in the University of Northern
Iowa's Human Performance Laboratory at the same times of day
for each subject.

Subjects reported to the laboratory three

times throughout the study.

On the first visit to the

laboratory, each subject was randomly assigned to one of the
following three groups:
1. Control (Con): (n = 7)-no ibuprofen administered.
2. Prophylactic ibuprofen (PI): (n = 7)-initial 600 mg
ibuprofen taken 1 hr before exercise followed by 200 mg
every 3-hr postexercise through 24-hr postexercise for a
total of 2,200 mg of ibuprofen.
3. Therapeutic ibuprofen, (TI): Cn = 12)-600 mg of
ibuprofen at 24 hr and 200 mg every 3 hr up to 48 hr postexercise for a total of 2,200 mg.
Baseline measures were made of each subject on the
following dependent variables: perceived muscle soreness,
anaerobic explosive power., fatigue index, maximal power, and
work capacity.
Soreness-Inducing Exercise Bout
The exercise bout consisted of downhill running on the
treadmill.

All running was performed on either a Quinton

Model 18-60 (Quinton Instruments, Seattle, Washington, USA)
or Marquette 2000 T (SensorMedics Corporation, Yorba Linda,
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California, USA) motorized treadmill.

Heart rates were

measured during exercise by telemetry using a Polar heart
rate monitor (Polar CIC Inc. Fort Washington, NY, USA).
The treadmill running begun with a 3-min warm-up.
Subjects begun 1 min of walking.

Afterwards, treadmill

speed was increased progressively for subjects to start
jogging for a 3-min warm-up.

Treadmill speed was adjusted

to attain a heart rate equivalent to 80% of estimated age
adjusted (220-Age) maximal heart rate of subject.

The

treadmill was then declined to -10% for running for another
30 minutes.

Following the 30 minutes of downhill running,

the treadmill speed was reduced to 2 k.hr-1 for a 2-min walk
for recovery.
Measurements
Prior to the baseline measures, subjects received
tutorials on the tests which were repeated at 0-hr
24-hr, and 48-hr post-exercise in the order presented below.
This order of presentation was adopted to avert the chances
of fatigue from a more intensive activity influencing the
results of subsequent tests.
Muscular Soreness
A visual analogue scale which had presumably been
tested for reliability and validity, as used by Redenburg,
Bar, and De Boer (1993), ranged from O (no soreness) to 6
(intolerable soreness) was employed, see Appendix E.
scale was shown to subjects and explained as a self-

The
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reporting estimate of their soreness by picking the most
appropriate adjective that describes muscle soreness on the
scale.

Soreness was measured in the following manner: from

an erect position with hands held in front, the subject bent
at the knees and hips until reaching 90 degrees at both the
hip and knee joints.

This position was held for 5 sec and

repeated three times separated by a 10-sec rest.

The

subject then perceptually assessed their feelings of pain
for all three trials and chose a number on the scale that
was representative of the extent of his soreness.
Vertical Jump
Assessment of each subject's maximal reach was made
initially.

Standing 10 cm from and facing a wall, subjects

rocked onto their toes and, with a powdered middle finger
made a spot on the wall.

The distance between the floor and

the spot was measured and taken as subject's reach.
Subjects then did five bound-offs and 1 min of stretching
activities as warm-up.

Subjects then dipped the tip of

middle finger of dominant hand into powdered chalk.
Standing perpendicular to and about 30 cm away from a wall,
subjects lowered their body by bending at the hip and knee
and jumped three times with 10 sec rest between jumps.

This

was performed maximally and placed a chalk mark on the wall
at the apex of the jumps.

Deviations of the height of the

chalk spots from subjects' reach were measured and the mean
value for the three repetitions was used.
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Anaerobic Work Capacity
Muscle work capacity was measured by using a 30-sec
Wingate test (Patton

&

Duggan, 1983).

A Monark 814 cycle

ergometer (Ergomedics Sweden) with a weighted pan was used.
A photocell (Sports Medicine Industries) interfaced with a
personal computer was used to count flywheel revolutions.
Before each test, the ergometer seat height was adjusted
such that at the lowest pedal propulsion the legs are fully
extended.

Subjects' feet were slotted into stirrups of the

pedal and warmed up on the cycle ergometer by gently
pedalling for 3 min.

Thereafter, subjects were instructed

to increase pedalling rate steadily.

On reaching maximal

pedal rate within 5-10 sec, a weight equivalent to 7.5% of
the subject's weight was applied.

Subjects were verbally

encouraged to maintain maximal effort during the 30-sec
test.

The weight was then removed while subjects pedalled

at low resistance for 3 min to recover.
Three variables were calculated by the computer:
(a) maximal power-highest power output within any 5-sec
period, (b) work output, and (c) rate of fatigue, the
percentage of power drop off.

To ensure compliance to the

requirements of the study, subjects were directed to
complete a general log which asked questions pertaining to
'

the timely ingestion of ibuprofen, abstention from smoking,
alcohol, exercise and ingestion of extra NSAIDs.

These

forms were reviewed for any indicators which might exclude a
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given subject from the study.

Subjects made second and

third visits to the laboratory to go through all but the
treadmill protocol at the same times with an interval of
approximately 24 hours.
Analysis of Data
A multivariate ANOVA with repeated measure on one
factor was used to determine the effects of the treatment on
muscle soreness and muscle performance and any interaction
effect.

Level of significance was established at .05.

Data

were entered into the mainframe computer at the University
of Northern Iowa and were analyzed using the Statistical
Package for the Social Sciences (SPSS).
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CHAPTER IV
RESULTS AND DISCUSSION

The purpose of the study was to investigate whether
ingestion of ibuprofen prior to or after a muscle-damaging
exercise would reduce muscle soreness.

A secondary purpose

was to find out whether ingestion of ibuprofen would restore
diminished muscle performance more quickly than without
ibuprofen.

The primary research hypothesis was that use of

ibuprofen before or after the damage-inducing exercise would
reduce muscle soreness and diminished muscle performance.
Furthermore, prophylactic administration of ibuprofen was
hypothesized to cause a greater reduction in soreness and
diminished muscle performance.
Results
Twenty-one subjects completed all parts of the study.
The mean age and weight of the subjects completing the study
were 20.3 ± 1.7 yr and 77.4 ± 7.8 kg, respectively.
Subjects' physical characteristics and raw data are
presented in Appendix F.

In Table 1 descriptive statistics

of subjects at preexercise, 0-hr, 24-hr, and 48-hr
postexercise of muscle soreness, fatigue, vertical jump,
maximal power, and work capacity are presented.
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Table 1
Descriptive Statistics of Soreness, Vertical Jump, Maximal
Power, and Work Capacity (N = 21}

Control

Prophylactic

Therapeutic

Muscle Soreness (V/A Scale)
PreEx

0.43 + 0.79

0.29

2.29

0.76*

2.43 + 1.51*

2.15 .± 1.21*

24 hr

3.00 .± 1.41*

2.29 + 1.50*

3.29

48 hr

3.43

2.14

1.35*

2.71 + 1.38*

0 hr

±
±

1.62*

±

±

0.49

0.14

±
±

0.38

0.95*

Vertical Jump (cm)
PreEx

43.33

±

2.51

42.40 .± 3.73

45.90 .± 4.74

0 hr

40.90

±

2.26

40.15 + 3.72

42.40

±

5.25

24 hr

41.24 + 2.32

40.36

3.68

40.06 + 4.90

48 hr

41.40 + 2.21

41.07 .± 3.91

41.46 + 4.03

±

Fatigue Index (%)
PreEx
0 hr

27.09 + 12.00

24.13 .±

9.50

27.67

±

7.67

18.37

24.54 + 18.89

31.57

±

9.88

±

10.36

24 hr

35.09 .± 15.38

29.19 +

7.79

36.99

±

7.50

48 hr

26.66

36.61 + 14.68

30.04

±

5.66

±

13.55

{:table continued}
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Control

Prophylactic

Therapeutic

Maximal Power (W)
PreEx

908.14 ±

89.32

813.43 +

53.23

857.86 ± 120.28

0 hr

834.43 +

72.68

833.71 ±

62.22

844.14 ± 161.88

24 hr

919.57 + 111.75

882.00 ±

68.75

873.43 ± 162.19

48 hr

920.43 +

815.29 ± 103.97

894.71 + 180.75

97.70

Work Capacity (kJ)
PreEx

23.57 + 17.53

21.56 + 16.44

22.53 ± 36.62

0 hr

22.84 ± 18.30

22.55 ± 18.73

20.37 ± 21.64

24 hr

23.43 ± 34.39

22.62 ± 17.34

21.57 ± 47.64

48 hr

24.34 + 24.45

20.59 + 28.73

22.86 ± 52.09

Note.

There were no significant main or time effects

between the treatment and control groups (R > .05).
*=Significantly different from preexercise values
(R

< .05).

PreEx = Preexercise.

Muscle Soreness
In all groups, muscle soreness significantly increased
after the exercise protocol for all postexercise periods
compared to preexercise values.

However, there were no
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significant differences at any of the preexercise and
postexercise measuring times between treatment and control
groups.
Fatigue Index
Preexercise and postexercise changes in fatigue index
did not show any significant differences between treatment
and control groups.
Vertical Jump
At all measuring times, vertical jump values between
treatment and control groups were not significantly
different.
Maximal Power
At preexercise and all postexercise measuring times,
there were no significant differences between treatment and
control groups.
Work Capacity
Postexercise changes in work capacity from baseline
values were highly variable.

Work capacity at Ohr and

24-hr postexercise, relative to preexercise, decreased in
the control and therapeutic groups.

In the prophylactic

group however, work capacity increased above preexercise
value.

At 48-hr postexercise, a reverse of the situation

was observed.

In spite of these inconsistencies and

variabilities, there were no significant differences in work
capacity of the treatment and control groups at all
measuring times.
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Discussion
The present study was designed to measure two
conditions of ibuprofen administration to test its
effectiveness in reducing muscle soreness and restoration of
diminished muscle performance following a damage-inducing
exercise.

A 2,200-mg prophylactic administration of

ibuprofen ingested over 24 hr was intended to ensure peak
plasma level of ibuprofen before exercise (Pyne, 1994).

The

therapeutic administration was given 24-hr postexercise and
was hypothesized to prevent further damage from occurring.
The present study failed to demonstrate the
effectiveness of ibuprofen in reducing muscle soreness and
diminished muscle performance.

The findings are in

agreement with the conclusions of other studies.

Donnelly

Maughan, and Whiting (1990) found ibuprofen ineffective in
the treatment of DOMS or muscle strength loss at a total
dosage of 8,400 mg over 24 hr.

Also, Kuipers et al. (1985)

concluded that flurbiprofen, an ibuprofen-related drug, was
ineffective in the treatment of DOMS.

The lack of treatment

effect by ibuprofen could be attributed to a combination of
at least two factors.
First, Gracely and Kwilosz (1988) have suggested that
subjectjve assessment of pain is associated with a flaw
termed as scaling error.

From their view, repetitive use of

the same soreness scale has the potential to provide
subjects with the same category or part of a line or to
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remember past specific response.

They did not, however,

indicate any likelihood of differences in pain measurement
due to the flaw.

They further argue that since pain

sensation has both sensory and physiologic components, a
more versatile instrument should be designed to measure
DOMS.

Contrary to expectations, all three groups in this

study had some level of soreness at preexercise time.

This

likely implies that some bodily discomfort other than
soreness was being measured.
Second, the period of soreness evaluation may not have
been long enough for any distinct intergroup differences to
be observed in subjects in the postexercise period.

It is

possible that, beyond 48-hr postexercise, the rate of muscle
soreness decrease in the treatment group could be faster
than in the control group.

Even though the prophylactic

group ingested an initial 600 mg of ibuprofen 1 hour prior
to the treadmill run, no marked effect was observed on
muscle soreness and muscle performance.
Whereas dosage has a potential influence on the level
of muscle soreness in human subjects, McCormack and Brune
(1991) suggested that when administering NSAIDs, the target
pain must be intense enough to significantly distinguish
perceived soreness of the treatment group from placebo
group.

To date, studies which tested ibuprofen for its

effectiveness in regressing DOMS are inconclusive in their
findings.

At 500 mg, diclofenac, an ibuprofen-related
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NSAID, was effective in reducing soreness at specific spots
in humans (Donnelly, McCormick, Maughan, Whiting, &
Clarkson, 1988).

Hasson et al. (1993) administered a total

of 1,200 mg/day of ibuprofen in a study and found it
effective in reducing both muscle soreness and diminished
muscle performance.
Additional factors that could possibly cause lack of
treatment effect are the exercise protocol employed,
duration of exercise bout and dosage/duration interaction of
drug administration.

As evidence, Hasson et al. (1993)

found ibuprofen effective in reducing both muscle soreness
and diminished muscle performance.

Subjects performed step-

ups in which lowering the body was done on one leg to induce
muscle soreness.

Because this movement is not as common in

human motion as running exercise, it may have caused greater
damage than from the 30-min downhill running utilized in the
present study.

This was supported from the lack of

difference between preexercise and postexercise values of
the fatigue index and work capacity.
Exercise duration poses a critical factor in
determining extent of damage.

Kuipers et al. (1985) had

subjects perform eccentric cycling for 30 min at 80% of
maximal oxygen uptake.

Later, subjects performed the same

activity for 45 and 60 min.

In subjects who performed for

30 min, histological examination did not show any
inflammation.

Subjects in the 45-min and 60-min exercise
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bouts groups however, showed inflammation.

Similarly,

Schwane and Armstrong (1983) noticed pronounced enzyme
release, a marker of sarcolemma damage, in subjects who
performed downhill running for 45 min but not after 30 min.
Since the present protocol lasted only 30 min, it is
possible that the duration and/or intensity were not enough
to induce sufficient tissue damage.
Dosage/duration interaction of drug administration
seems a more reasonable factor to consider in attempting to
establish lack of treatment effect of a drug.

Considering

dosage or duration of treatment alone there is seemingly
little certainty about what impact each factor could exert
on DOMS and diminished muscle performance.

It is therefore

reasonable to concede that a more versatile factor would be
a combination of the two.

Credence to this view is given in

a study by McLatchie et al. (1985).

The study was designed

to justify the benefits for the use of NSAIDs in injuries
which when left untreated would eventually heal.

In the 3-

day study, 144 sport persons who had sustained Grade 1 (mild
stretching of the ankle ligament with no instability) or
Grade 2 injury (moderate sprain with incomplete tear and
mild instability) were randomly assigned to ibuprofen
groups, 600 mg/4 daily; 1200 mg/2 daily and placebo
ibuprofen group.

Subjects were assessed at Day 1, Day 3,

and Day 7 for joint tenderness, muscle movement, overall
severity, and match fitness.

Even though the results

44
indicated significant treatment effect in both active
treatment groups, the 4 times daily group was superior.
Relating to the findings, this suggest that the dosage
utilized in the current study was insufficient to reduce
soreness.
Results from the vertical jump, fatigue index, maximal
power, and work capacity tests fluctuated considerably from
preexercise values.

This is very misleading, yet, does not

conceal probable reasons underlying the lack of treatment
effect on performance.

In the present study, vertical jump

in the respective groups declined from preexercise values at
all postexercise times which implies that the exercise bout
had affected performance.

Supportive of this, two subjects

randomly chosen had increased thigh circumferences at 24-hr
postexercise.

The fatigue indexes for the control group at

0-hr and 48-hr postexercise were not significantly lower
than preexercise levels.
An interesting phenomenon that this study did not
observe is a second loss in force in mice as reported by
Faulkner et al. (1993).

They reported that the second loss

of force in the postexercise period might be related to
DOMS.

Faulkner et al. (1993) believed that the initial loss

in force could be a factor of mechanical injury and fatigue.
They also suggested that a second biochemical injury occurs
to the muscle as a result of the phagocytic activity at the
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site of original damage possibly causing deterioration in
the muscle fiber resulting in loss of force.
Perhaps the most surprising findings of this study is a
seemingly lack of relationship between the fatigue index and
maximal power.

In all groups, fatigue index was greater at

all postexercise times except for the control group at 0-hr
and 48-hr.

However, the postexercise increases of the

fatigue index did not correspond to the postexercise
decrements in maximal power.

The correlation coefficients

for fatigue and maximal power for the four measuring times
were as follows: preexercise (£ = .291), 0 hr(£= .959), 24
hr (r = .248), and 48 hr(£= .138).
If the exercise protocol in the present study did not
cause sufficient damage, then a possible speculation that
can be made is that damage which results in ultrastructural
disorganization in fiber may be a more potent factor in
determining muscle function.

The speculation is based on

the assumption that the intensity and duration of the
exercise protocol were not enough to cause sufficient damage
to the muscle fibers even though some level of soreness was
experienced, postexercise levels of muscle performance
remained higher.

It is possible that if the exercise

protocol had caused maximal structural damage to the
mus~les, force production could have been impaired.

In

46summary, the findings of this study failed to support the
capability of ibuprofen in reducing muscle soreness and
diminished muscle performance at a dosage of 2,200 mg/24 hr.
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CHAPTER V
CONCLUSIONS, IMPLICATIONS, AND RECOMMENDATIONS
FOR FURTHER STUDIES
The purpose of this study was to investigate whether
the ingestion of ibuprofen before and after a muscledamaging activity would reduce exercise-induced muscle
soreness.

A second purpose was to investigate whether the

ibuprofen would greatly cause decrements in diminished
muscle performance.

Thirdly, the study investigated which

of the two modes of drug administration, prophylactic and
therapeutic, is superior in reducing soreness and diminished
muscle performance.
Conclusions
Based on the results of this study, the researcher
concluded that:
1.

Ibuprofen at a total dosage of 2,200 mg/day does

not diminish DOMS up to 48-hr postexercise.
2.

Ibuprofen does not help·restore muscle performance

more quickly in treatment group than in control group
following a 30-min downhill (-10% grade) treadmill run.
3.

Prophylactic treatment was not superior to either

therapeutic or control in reducing DOMS and restoring muscle
performance.
Implications
From the results of this study, it could be suggested
that the use of ibuprofen, a common practice among athletes
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may not, after all, be beneficial for purpose of reducing
DOMS and restoring muscle performance.
Recommendations for Further Study
Based on the results of this study, the following
recommendations for repeated studies are made:
1.

The use of a larger sample size so as to attain a

threshold point where group differences in treatment if any,
would be distinct.
2.

The employment of a more standardized and objective

soreness measuring instrument in assessing muscle soreness.
3.

Use of an additional questionnaire that would

incorporate both the affective and sensory components to
pain (Gracely & Kwilosz, 1988).
4.

Use of homogeneous subjects.

Test for similarities

in physical characteristics in terms of age of age, sex
athletic level and skill should be conducted prior to
participation (Bar-Or, 1987).
5.

Increased dosage and longer period of ibuprofen

administration.
6.

Extension of postexercise period of testing and

data collection must be made to ensure that a point is
reached where group difference in response to treatment
become distinct.
7.

Employment of a more intense and longer duration

exercise is recommended.
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8.

Assessment of muscle performance should be done

side-by-side with muscle biopsy in order to measure changes
in performance against any possible morphological
irregularities and changes in blood variables like creatine
kinase.

In this way, questionable trends in performance and

soreness can be matched against possible instrumental and
sampling errors.
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SUBJECTS IN~ORMED CONSENT
I hereby consent to take part in a research directed by
Atta Kofi Osei, School of Physical Education and Leisure
Services, University of Northern Iowa.

I understand that

other persons may assist this individual or be associated
with him.
I understand that:
1.

This research is to investigate the effect

ibuprofen may have on exercise-induced muscle pain.
2.

This will be my part in the research:

to have

soreness perception, muscle power and muscle capacity
assessed daily for three days; complete a 30-minute running
on a treadmill declined to -10%, on the first visit; orally
ingest the required dosage of ibuprofen as stipulated by the
study; stay away from massaging or ingestion of additional
dosage of pain killers.

These procedures would be conducted

in the Human Performance Laboratory, 207 West Gymnasium,
UNI.

3.

Participation in the research will require

approximately a total 3 hours of my time.
4.

My participation is voluntary.

participating at any time.

I am free to stop

If I do not volunteer or if my

participation is ended for any reason by the researcher or
me, this will involve no penalty or loss of any of the
benefits to which I am entitled.
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5.

I will be told of any significant new information

that might affect my willingness to take part in this
research.
6.

These benefits can be expected from the research:

I will receive useful information about my age adjusted
(220-Age) maximum heart rate; muscle power and anaerobic
capacity, extent to which my sore muscle could sustain
itself under resistance, rate of my body's response to
NSAIDs and extent of treadmill running at -10% declination.
7.
risks:

My participation will expose me to the following
Leg instability to moderate intensity exercise for

30 minutes can cause leg fatigue and general tiredness.
Dizziness and loss of consciousness, although rare, are
likely results of explosive cycle ergometer pedalling.
Standard safety procedures will be used, and qualified
personnel will be present for assistance during exercise
testing.
8.

There are no other satisfactory procedures to

obtain information needed for this research.
9.

The following steps will be taken to protect the

confidentiality of my identity and the data I have
contributed:

All data will be filed in locked rooms.

Only

averages will be reported and the data will not be linked
with any individual in published or oral reports.

The

investigator will keep an identifier key, but the subjects
may request the identity link to his data to be destroyed.
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Otherwise, the data will be maintained in storage for an
indefinite period.
10.

I will receive no monetary or other compensation

for my time.
11.

I further allow Atta K. Osei and his assistants or

associates to perform the procedures referred to above,
report their findings to government agencies, funding
agencies, manufacturers, or scientific bodies, and to
publish their findings.
have been answered.

My questions about this research

If I do have any further questions, I

am to contact Atta K. Osei at the school office in West
Gymnasium, 273-2141 or 277-4629, 2113 Main Street, Cedar
Falls, IA 50613 or Dr. Fred Kolkhorst, 207B West Gymnasium,
273- 5921.

Questions regarding this research project and

the rights of research subjects also may be directed to the
Human Subjects Coordinator, University of Northern Iowa,
273-2748.

I am fully aware of the nature and extent of my

participation in this project as stated above and the
possible risks involved.
this project.

I hereby agree to participate in

I acknowledge receipt of a copy of this

consent statement.
Signature of Volunteer
Printed Name of Volunteer

Date
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SUBJECTS NOTATION SHEET

NAME:
CODE:

NOTE IF YOU DID ANY OF THE FOLLOWING:

1.
Yes

Did you involve in any vigorous physical activity?
No

If yes, what type and how long?
2.

Did you take additional pain killers or any drug to

suppress pain within the study period?

Yes

No

If yes, please indicate the type of medication dosage, and
day

1 (testing day)

2 (recovery day 1)

3 (recovery day 2)
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SUBJECTS PRETEST QUESTIONNAIRE
NAME:
CODE:

(Circle one)
1.

Do you have any known heart diseases?

Yes

No

2.

Do you have asthma?

Yes

No

3.

Do you have any physiological/physical impairment that

will make it difficult to:
*run on the treadmill?

Yes

No

*pedal the ergometer?

Yes

No

*jump the wall?

Yes

No

If yes, describe:

4.

Are you currently taking medications?

Yes

No

If yes, please list all medications and why you are
taking them.

S.

Please describe any regular physical activity you are

involved in.
*jogging (mileage)
*sport (name) duration and number of times per week.
*aerobic exercises/dancing; duration and number of
times per week.
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6.

Have you ever taken any pain killers?

(i.e. ibuprofen,

advil, tylenol, anacin, aspirin).

Yes

No

If yes, when was the last time?
What dosage?
How often do/did you take the said drug?
2*2 daily
7.

1*2 daily

2*1 daily

other (explain)

Have you ever taken any -sllbstance in order to regress

pain in physical performance?
If yes, please explain.

Yes

No
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SUBJECTS PERSONAL DATA SHEET

Code#: _ _ _ _ __

Name:
Age:

Reach: -----Soreness

PreEx
0 hr
24 hrs
48 hrs

Vet. Jump

Fatigue

Weight: _ __

Max. Power

Work Output
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VISUAL ANALOGUE SCALE
Numerical Rating

Description of Feelings

0

No Soreness

1

Dull feeling of soreness

2

Light continuous soreness

3

More than light soreness

4

Annoying soreness

5

Severe soreness

6

Intolerable soreness
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RAW DATA
PRE-EXERCISE
Grp Age

Subj 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

1
1
1
2
3
3
3
2
1
1
2
2
3
3
1
1
2
2
3
3
2

20
20
20
22
19
19
22
24
19
19
22
18
18
21
21
22
20
22
19
20
18

Wgt
(Kg)

Snss

85
81
77
76
74
86
81
78
77
69
76
74
75
85
98
81
67
62
68
80
74

0
0
2
1
0
0
0
0
0
0
0
0
0
1
0
1
0
1
0
0
0

Snss = Soreness
A'bic = Aerobic
An'bic = Anaerobic
Grp = Group
Wgt = Weight
Ftg = Fatigue
Pwr = Power
Jmp = Jump
Vert= Vertical

A'bic Power
Vert. Jmp
(Inch)

13
18
17
13
14
22
25
14
15
21
13
17
21
12
17
18
22
16
16
19
21

An'bic Wrk Capacity
Ftg Max.Pwr Work
(W)
(Kj)
(%)

31
26
45
31
16
30
30
34
19
10
21
20
23
29
38
20
34
07
26
41
22

922
937
936
867
1050
978
863
845
815
768
791
751
720
776
1037
942
767
784
820
789
889

25152
24937
21270
22723
29572
24775
22372
20540
22225
21666
20926
20248
20030
19769
24684
25024
19551
22992
22101
19104
23929
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RAW DATA
IMMEDIATE POST-EXERCISE
Snss.

Subj

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

2
3
3
4
2
4
1
1
2
1
2
4
3
3
2
3
4
2
1
1
1

A'bic Power
Vert. Jmp
(Inch)
13
17
17
13
13
22
23
14
16
20
11
16
20
11
15
15
21
16
11
18
20

Anaerobic Work Capacity
Ftg Mx. Power
Work
(W)
(Kj)
(%)
34
15
26
26
26
13
32
18
08
24
20
13
42
39
18
05
66
15
37
32
13

875
780
806
885
1167
853
895
788
750
880
826
742
839
675
958
792
840
933
741
739
822

23067
21468
21128
23719
21157
23825
21666
21800
22201
22227
22812
21038
20681
17597
26631
23127
19779
25497
19683
18003
23179
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RAW DATA
24-HOUR POST EXERCISE
Snss

Subj

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

4
4
5
3
2
4
2
2
1
2
0
5
4
4
2
3
2
2
4
3
2

A,bic Power
Vet. Jump
(inch)
13
15
16
13
12
21
23
14
17
20
12
16
19
12
18
15
21
16
12
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17226
23283
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